9,99 €
Health for all and patents on medicines: The major Rift
Par :Formats :
Disponible dans votre compte client Decitre ou Furet du Nord dès validation de votre commande. Le format PDF est :
- Compatible avec une lecture sur My Vivlio (smartphone, tablette, ordinateur)
- Compatible avec une lecture sur liseuses Vivlio
- Pour les liseuses autres que Vivlio, vous devez utiliser le logiciel Adobe Digital Edition. Non compatible avec la lecture sur les liseuses Kindle, Remarkable et Sony
, qui est-ce ?Notre partenaire de plateforme de lecture numérique où vous retrouverez l'ensemble de vos ebooks gratuitement
Pour en savoir plus sur nos ebooks, consultez notre aide en ligne ici
C'est si simple ! Lisez votre ebook avec l'app Vivlio sur votre tablette, mobile ou ordinateur :
- Nombre de pages88
- FormatPDF
- ISBN978-2-487682-38-2
- EAN9782487682382
- Date de parution01/06/2024
- Protection num.pas de protection
- Taille860 Ko
- Infos supplémentairespdf
- ÉditeurA PRECISER
Résumé
The gap between health for all and the imperative of profitability of patents on medicines is enormous. This work highlights the eternal conflict between health for all and the imperative of profitability of intellectual property linked to patents on medicines in the pharmaceutical industry. Health for all is difficult to reconcile with the need for patent profitability. Obtaining a patent for a drug rhymes with an obligation of profitability.
The expiration of the patent on the drug generates strategies on the part of pharmaceutical companies that are not in the service of health. Does health have a price?
The expiration of the patent on the drug generates strategies on the part of pharmaceutical companies that are not in the service of health. Does health have a price?
The gap between health for all and the imperative of profitability of patents on medicines is enormous. This work highlights the eternal conflict between health for all and the imperative of profitability of intellectual property linked to patents on medicines in the pharmaceutical industry. Health for all is difficult to reconcile with the need for patent profitability. Obtaining a patent for a drug rhymes with an obligation of profitability.
The expiration of the patent on the drug generates strategies on the part of pharmaceutical companies that are not in the service of health. Does health have a price?
The expiration of the patent on the drug generates strategies on the part of pharmaceutical companies that are not in the service of health. Does health have a price?
A propos de Sabine Ndzengue Amoa
9,99 €
11,50 €
17,00 €
20,00 €